The intercellular adhesion molecule-1 polymorphisms in IBD
2002-01-01 Li, Jh; Yang, Xs; Cullen, S; Lin, Kl; Armuzzi, A; Ahmad, T; Neville, Mj; Walton, R; Jewell, D
INFLIXIMAB IN STEROID-DEPENDENT ULCERATIVE COLITIS
2011-01-01 Armuzzi, A; Pugliese, D; Marzo, M; Felice, C; Andrisani, G; De Vincentis, F; Mocci, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L
Infliximab in Steroid-Dependent Ulcerative Colitis
2011-01-01 Armuzzi, A; Pugliese, D; Marzo, M; Felice, C; Andrisani, G; Vitale, G; Mocci, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L
The 5q31/IBD5 risk haplotype determines perianal phenotype in Crohn's disease
2002-01-01 Armuzzi, A; Ahmad, T; De Silva, Ap; Ling, K; Cullen, S; Van Heel, D; Jewell, D
Quantification of Microvascular Activation in Ileal Crohn's Disease By Software Elaboration Data Applied to CEUS: Correlation with Biological Activity Indexes
2009-01-01 De Franco, A; Di Veronica, A; Guidi, L; Armuzzi, A; De Vitis, I; Papa, A; Marzo, M; Felice, C; Bock, E; Bonomo, L
PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C VIRUS INFECTION IN A LARGE COHORT OF PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE IN TREATMENT WITH ANTI-TNF-A AGENTS
2011-01-01 Papa, A; Armuzzi, A; Marzo, M; Felice, C; Mocci, G; Andrisani, G; Pugliese, D; Scaldaferri, F; De Vitis, I; Gasbarrini, A; Rapaccini, G; Covino, M; Guidi, L
Influence of the IBD5/5q31 cytokine cluster haplotype an celiac disease genetic susceptibility
2002-01-01 Van Heel, D; Mcgovern, Dp; Negoro, K; Armuzzi, A; Segal, S; Ahmed, T; Barnardo, M; Anderson, Rp; Jewell, D
Mono, dual and triple moxifloxacin-based regimens for Helicobacter pylori eradication
2001-01-01 Di Caro, S; Ojetti, V; Zocco, Ma; Cremonini, F; Bartolozzi, F; Armuzzi, A; Gabrielli, M; Candelli, M; Sanz-Torre, E; Nista, E; Lupascu, A; Cammarota, G; Gasbarrini, G; Gasbarrini, A
Antibiotic resistance of H-pylori strains obtained by dyspeptic patients not eradicated by two consecutive eradication regimens
1998-01-01 Gasbarrini, A; Branca, G; Ojetti, V; Candeloro, L; De Vitis, I; Franceschi, E; Torre, Es; Candelli, M; Armuzzi, A; Pola, R; Anti, M; Pola, P; Fadda, G; Gasbarrini, G
Fecal calprotectin in Inflammatory Bowel Disease treated with anti-TNF agents
2009-01-01 Marzo, M; Armuzzi, A; Felice, C; Forni, F; Papa, A; De Vitis, I; Guidi, L
In Vivo and In Vitro Immune Response to Pandemic Influenza 2009 H1N1 Vaccine in Inflammatory Bowel Disease Patients on Anti TNF-Alpha Treatment
2011-01-01 Andrisani, G; Frasca, D; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Mocci, G; Pugliese, D; De Vitis, I; Rapaccini, Gl; Guidi, L
High prevalence of Helicobacter pylori infection in recurrent spontaneous abortion
1999-01-01 Torre, Es; Gasbarrini, A; Trivellini, C; De Carolis, S; Camilli, Fm; Ojetti, V; Franceschi, F; Candelli, M; Armuzzi, A; Gabrielli, M; Danese, S; Canducci, F
Complex Perianal Crohn's Disease: Effectiveness of Combined Seton Placement and Anti-TNF Alpha Agents in Monotherapy or in Association With Immunosuppressants
2012-01-01 Armuzzi, A; Marzo, M; Felice, C; Pugliese, D; Andrisani, G; Parello, A; De Vitis, I; Rapaccini, Gl; Papa, A; Ratto, C; Guidi, L
Efficacy of lactobacillus GG in decreasing antibiotic-associated gastrointestinal morbidity during H. pylori eradication regimen
1999-01-01 Armuzzi, A; Gasbarrini, A; Franceschi, F; Ojetti, V; Candelli, M; Torre, Es; Gabrielli, M; Di Campli, C; Carloni, E; Zocco, Ma; De Lorenzo, A; Gasbarrini, G
Usefulness of C-13-methionine breath test as a non-invasive and dynamic tool to evaluate residual hepatic mitochondrial function
1998-01-01 Gasbarrini, A; Armuzzi, A; Marcoccia, S; Grieco, A; Anti, M; Pola, P; Gasbarrini, G
Epithelial cell proliferation in gastric mucosa of Helicobacter pylori gastritis: Immunohistochemical study in a high gastric cancer risk population
1996-01-01 Baldini, L; Bonvicini, F; Epifanio, G; Pretolani, S; Fasanella, C; Cogliandro, L; Armuzzi, A; Miglio, F; Gasbarrini, G
INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS ON ANTI TNF-ALPHA THERAPY: RESPONSE TO THE INFLUENZA A/H1N1 VACCINE
2011-01-01 Andrisani, G; Frasca, D; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Mocci, G; Pugliese, D; Vitale, G; De Vitis, I; Rapaccini, Gl; Guidi, L
Long-Term Scheduled Therapy with Infliximab in Inflammatory Bowel Disease
2009-01-01 Armuzzi, A; De Vincentis, F; Marzo, M; Mocci, G; Felice, C; Fedeli, P; De Vitis, I; Papa, A; Gasbarrini, A; Guidi, L
Efficacy and Safety of Low-Molecular Weight Heparin for the Prevention of Venous Thromboembolism in Patients With Severe Ulcerative Colitis
2012-01-01 Papa, A; Armuzzi, A; Guidi, L; Marzo, M; Felice, C; Andrisani, G; Mocci, G; Pugliese, D; De Vitis, I; Gasbarrini, A; Rapaccini, Gl
Role of the HLA in determining susceptibility and phenotype in Caucasian ulcerative colitis (LIC)
2002-01-01 Ahmad, T; Armuzzi, A; Bunce, M; Mulcahy-Hawes, K; Crawshaw, J; Large, O; Welsh, K; Jewell, D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The intercellular adhesion molecule-1 polymorphisms in IBD | 1-gen-2002 | Li, Jh; Yang, Xs; Cullen, S; Lin, Kl; Armuzzi, A; Ahmad, T; Neville, Mj; Walton, R; Jewell, D | |
| INFLIXIMAB IN STEROID-DEPENDENT ULCERATIVE COLITIS | 1-gen-2011 | Armuzzi, A; Pugliese, D; Marzo, M; Felice, C; Andrisani, G; De Vincentis, F; Mocci, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L | |
| Infliximab in Steroid-Dependent Ulcerative Colitis | 1-gen-2011 | Armuzzi, A; Pugliese, D; Marzo, M; Felice, C; Andrisani, G; Vitale, G; Mocci, G; De Vitis, I; Papa, A; Rapaccini, Gl; Guidi, L | |
| The 5q31/IBD5 risk haplotype determines perianal phenotype in Crohn's disease | 1-gen-2002 | Armuzzi, A; Ahmad, T; De Silva, Ap; Ling, K; Cullen, S; Van Heel, D; Jewell, D | |
| Quantification of Microvascular Activation in Ileal Crohn's Disease By Software Elaboration Data Applied to CEUS: Correlation with Biological Activity Indexes | 1-gen-2009 | De Franco, A; Di Veronica, A; Guidi, L; Armuzzi, A; De Vitis, I; Papa, A; Marzo, M; Felice, C; Bock, E; Bonomo, L | |
| PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C VIRUS INFECTION IN A LARGE COHORT OF PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE IN TREATMENT WITH ANTI-TNF-A AGENTS | 1-gen-2011 | Papa, A; Armuzzi, A; Marzo, M; Felice, C; Mocci, G; Andrisani, G; Pugliese, D; Scaldaferri, F; De Vitis, I; Gasbarrini, A; Rapaccini, G; Covino, M; Guidi, L | |
| Influence of the IBD5/5q31 cytokine cluster haplotype an celiac disease genetic susceptibility | 1-gen-2002 | Van Heel, D; Mcgovern, Dp; Negoro, K; Armuzzi, A; Segal, S; Ahmed, T; Barnardo, M; Anderson, Rp; Jewell, D | |
| Mono, dual and triple moxifloxacin-based regimens for Helicobacter pylori eradication | 1-gen-2001 | Di Caro, S; Ojetti, V; Zocco, Ma; Cremonini, F; Bartolozzi, F; Armuzzi, A; Gabrielli, M; Candelli, M; Sanz-Torre, E; Nista, E; Lupascu, A; Cammarota, G; Gasbarrini, G; Gasbarrini, A | |
| Antibiotic resistance of H-pylori strains obtained by dyspeptic patients not eradicated by two consecutive eradication regimens | 1-gen-1998 | Gasbarrini, A; Branca, G; Ojetti, V; Candeloro, L; De Vitis, I; Franceschi, E; Torre, Es; Candelli, M; Armuzzi, A; Pola, R; Anti, M; Pola, P; Fadda, G; Gasbarrini, G | |
| Fecal calprotectin in Inflammatory Bowel Disease treated with anti-TNF agents | 1-gen-2009 | Marzo, M; Armuzzi, A; Felice, C; Forni, F; Papa, A; De Vitis, I; Guidi, L | |
| In Vivo and In Vitro Immune Response to Pandemic Influenza 2009 H1N1 Vaccine in Inflammatory Bowel Disease Patients on Anti TNF-Alpha Treatment | 1-gen-2011 | Andrisani, G; Frasca, D; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Mocci, G; Pugliese, D; De Vitis, I; Rapaccini, Gl; Guidi, L | |
| High prevalence of Helicobacter pylori infection in recurrent spontaneous abortion | 1-gen-1999 | Torre, Es; Gasbarrini, A; Trivellini, C; De Carolis, S; Camilli, Fm; Ojetti, V; Franceschi, F; Candelli, M; Armuzzi, A; Gabrielli, M; Danese, S; Canducci, F | |
| Complex Perianal Crohn's Disease: Effectiveness of Combined Seton Placement and Anti-TNF Alpha Agents in Monotherapy or in Association With Immunosuppressants | 1-gen-2012 | Armuzzi, A; Marzo, M; Felice, C; Pugliese, D; Andrisani, G; Parello, A; De Vitis, I; Rapaccini, Gl; Papa, A; Ratto, C; Guidi, L | |
| Efficacy of lactobacillus GG in decreasing antibiotic-associated gastrointestinal morbidity during H. pylori eradication regimen | 1-gen-1999 | Armuzzi, A; Gasbarrini, A; Franceschi, F; Ojetti, V; Candelli, M; Torre, Es; Gabrielli, M; Di Campli, C; Carloni, E; Zocco, Ma; De Lorenzo, A; Gasbarrini, G | |
| Usefulness of C-13-methionine breath test as a non-invasive and dynamic tool to evaluate residual hepatic mitochondrial function | 1-gen-1998 | Gasbarrini, A; Armuzzi, A; Marcoccia, S; Grieco, A; Anti, M; Pola, P; Gasbarrini, G | |
| Epithelial cell proliferation in gastric mucosa of Helicobacter pylori gastritis: Immunohistochemical study in a high gastric cancer risk population | 1-gen-1996 | Baldini, L; Bonvicini, F; Epifanio, G; Pretolani, S; Fasanella, C; Cogliandro, L; Armuzzi, A; Miglio, F; Gasbarrini, G | |
| INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS ON ANTI TNF-ALPHA THERAPY: RESPONSE TO THE INFLUENZA A/H1N1 VACCINE | 1-gen-2011 | Andrisani, G; Frasca, D; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Mocci, G; Pugliese, D; Vitale, G; De Vitis, I; Rapaccini, Gl; Guidi, L | |
| Long-Term Scheduled Therapy with Infliximab in Inflammatory Bowel Disease | 1-gen-2009 | Armuzzi, A; De Vincentis, F; Marzo, M; Mocci, G; Felice, C; Fedeli, P; De Vitis, I; Papa, A; Gasbarrini, A; Guidi, L | |
| Efficacy and Safety of Low-Molecular Weight Heparin for the Prevention of Venous Thromboembolism in Patients With Severe Ulcerative Colitis | 1-gen-2012 | Papa, A; Armuzzi, A; Guidi, L; Marzo, M; Felice, C; Andrisani, G; Mocci, G; Pugliese, D; De Vitis, I; Gasbarrini, A; Rapaccini, Gl | |
| Role of the HLA in determining susceptibility and phenotype in Caucasian ulcerative colitis (LIC) | 1-gen-2002 | Ahmad, T; Armuzzi, A; Bunce, M; Mulcahy-Hawes, K; Crawshaw, J; Large, O; Welsh, K; Jewell, D |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2184
Data di pubblicazione
- 2020 - 2026115
- 2010 - 20191351
- 2000 - 2009606
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...124
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng817
- ita28
- und6
Accesso al fulltext
- no fulltext2131
- reserved51
- open2